BOYCE, CHRISTOPHER, W.,FEVRIER, SALEM,MCCORMICK, KEVIN, D.,PALANI, ANANDAN,ASLANIAN, ROBERT, G.,SILIPHAIVANH, PHIENG,METHOT, JOEY, L.,BROWN, WILLIAM COLBY,VACCARO, HENRY
申请号：
EP11850226
公开号：
EP2661265A4
申请日:
2011.12.19
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
The invention provides certain quinolines and aza-quinolines of the Formula (I), and their pharmaceutically acceptable salts, wherein E, J1, Ja, Jb, R2, R3, R22, Ra, Rb, Rc, Rd, X, Y, b, n, and q are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions associated with uncontrolled or inappropriate stimulation of CRTH2 function.
